Filing Details
- Accession Number:
- 0001209191-24-005283
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-10 20:38:22
- Reporting Period:
- 2024-04-08
- Accepted Time:
- 2024-04-10 20:38:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1260990 | Oncternal Therapeutics Inc. | ONCT | Pharmaceutical Preparations (2834) | 621715807 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1634189 | James Robert Wills | 12230 El Camino Real, Suite 230 San Diego CA 92130 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-08 | 3,086 | $8.96 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The common stock purchase is matchable under Section 16(b) of the Securities Exchange Act of 1934, but the reporting person previously paid the Issuer the full amount of the profit realized in connection with the short swing transaction. No further amounts are required to be disgorged.
- The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $8.76 to $9.00. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.
Billionaire Hedge Funds
